Your browser doesn't support javascript.
loading
Family history of Alzheimer's disease alters cognition and is modified by medical and genetic factors.
Talboom, Joshua S; Håberg, Asta; De Both, Matthew D; Naymik, Marcus A; Schrauwen, Isabelle; Lewis, Candace R; Bertinelli, Stacy F; Hammersland, Callie; Fritz, Mason A; Myers, Amanda J; Hay, Meredith; Barnes, Carol A; Glisky, Elizabeth; Ryan, Lee; Huentelman, Matthew J.
Affiliation
  • Talboom JS; The Translational Genomics Research Institute, Phoenix, United States.
  • Håberg A; Arizona Alzheimer's Consortium, Phoenix, United States.
  • De Both MD; Norwegian University of Science and Technology, Trondheim, Norway.
  • Naymik MA; The Translational Genomics Research Institute, Phoenix, United States.
  • Schrauwen I; Arizona Alzheimer's Consortium, Phoenix, United States.
  • Lewis CR; The Translational Genomics Research Institute, Phoenix, United States.
  • Bertinelli SF; Arizona Alzheimer's Consortium, Phoenix, United States.
  • Hammersland C; The Translational Genomics Research Institute, Phoenix, United States.
  • Fritz MA; Arizona Alzheimer's Consortium, Phoenix, United States.
  • Myers AJ; The Translational Genomics Research Institute, Phoenix, United States.
  • Hay M; Arizona Alzheimer's Consortium, Phoenix, United States.
  • Barnes CA; The Translational Genomics Research Institute, Phoenix, United States.
  • Glisky E; The Translational Genomics Research Institute, Phoenix, United States.
  • Ryan L; The Translational Genomics Research Institute, Phoenix, United States.
  • Huentelman MJ; University of Miami, Miami, United States.
Elife ; 82019 06 18.
Article in En | MEDLINE | ID: mdl-31210642
In humans, a first-degree family history of dementia (FH) is a well-documented risk factor for Alzheimer's disease (AD); however, the influence of FH on cognition across the lifespan is poorly understood. To address this issue, we developed an internet-based paired-associates learning (PAL) task and tested 59,571 participants between the ages of 18-85. FH was associated with lower PAL performance in both sexes under 65 years old. Modifiers of this effect of FH on PAL performance included age, sex, education, and diabetes. The Apolipoprotein E ε4 allele was also associated with lower PAL scores in FH positive individuals. Here we show, FH is associated with reduced PAL performance four decades before the typical onset of AD; additionally, several heritable and non-heritable modifiers of this effect were identified.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cognition / Alzheimer Disease Type of study: Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Elife Year: 2019 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cognition / Alzheimer Disease Type of study: Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Elife Year: 2019 Document type: Article Affiliation country: Country of publication: